Yinan Ding

1.3k total citations · 1 hit paper
21 papers, 1.1k citations indexed

About

Yinan Ding is a scholar working on Biomedical Engineering, Molecular Biology and Immunology. According to data from OpenAlex, Yinan Ding has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Biomedical Engineering, 10 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Yinan Ding's work include Nanoplatforms for cancer theranostics (12 papers), Extracellular vesicles in disease (6 papers) and RNA Interference and Gene Delivery (4 papers). Yinan Ding is often cited by papers focused on Nanoplatforms for cancer theranostics (12 papers), Extracellular vesicles in disease (6 papers) and RNA Interference and Gene Delivery (4 papers). Yinan Ding collaborates with scholars based in China, Bangladesh and Singapore. Yinan Ding's co-authors include Qiusha Tang, Yanli An, Chen He, Gang Jia, Yong Han, Xihui Wang, Xihui Wang, Rui Yang, Weiping Yu and Chunmei Hu and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Biomaterials.

In The Last Decade

Yinan Ding

20 papers receiving 1.1k citations

Hit Papers

NRP-1 targeted and cargo-loaded exosomes facilitate simul... 2018 2026 2020 2023 2018 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yinan Ding China 12 707 419 353 266 105 21 1.1k
Chen He China 10 696 1.0× 363 0.9× 333 0.9× 239 0.9× 87 0.8× 20 1.0k
Kaylin M. McMahon United States 17 581 0.8× 195 0.5× 313 0.9× 194 0.7× 86 0.8× 26 976
Meghna Mehta United States 15 732 1.0× 260 0.6× 304 0.9× 236 0.9× 71 0.7× 20 1.1k
Gang Jia China 4 560 0.8× 277 0.7× 311 0.9× 157 0.6× 77 0.7× 5 768
Ranganayaki Muralidharan United States 14 723 1.0× 352 0.8× 239 0.7× 410 1.5× 92 0.9× 18 1.2k
Seung Rim Hwang South Korea 16 569 0.8× 202 0.5× 191 0.5× 185 0.7× 56 0.5× 38 1.0k
Yun Zhou China 24 857 1.2× 400 1.0× 369 1.0× 174 0.7× 228 2.2× 66 1.6k
Hongyue Jin China 10 557 0.8× 459 1.1× 161 0.5× 513 1.9× 118 1.1× 10 1.2k

Countries citing papers authored by Yinan Ding

Since Specialization
Citations

This map shows the geographic impact of Yinan Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yinan Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yinan Ding more than expected).

Fields of papers citing papers by Yinan Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yinan Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yinan Ding. The network helps show where Yinan Ding may publish in the future.

Co-authorship network of co-authors of Yinan Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Yinan Ding. A scholar is included among the top collaborators of Yinan Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yinan Ding. Yinan Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Luhong, et al.. (2025). Advancements in the application of ablative therapy and its combination with immunotherapy in anti-cancer therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1880(2). 189285–189285. 3 indexed citations
2.
Zhou, Han, Yi Jiang, Sisi Chen, et al.. (2025). Lipid Nanovesicles in Cancer Treatment: Improving Targeting and Stability of Antisense Oligonucleotides. Drug Design Development and Therapy. Volume 19. 1001–1023. 3 indexed citations
3.
Guo, Jingxing, Yinan Ding, Yuru Wang, et al.. (2025). SERS‐Guided Precision Resection Combined with Photothermal‐Immunotherapy for Glioblastoma Recurrence Prevention. Advanced Functional Materials. 35(44).
4.
Yang, Rui, Yanli An, Yinan Ding, et al.. (2024). NIR-promoted ferrous ion regeneration enhances ferroptosis for glioblastoma treatment. Journal of Controlled Release. 368. 595–606. 12 indexed citations
6.
Li, Yang, Yinan Ding, Jinghao Wang, et al.. (2024). A novel molecular classification system based on the molecular feature score identifies patients sensitive to immune therapy and target therapy. Frontiers in Immunology. 15. 1466069–1466069. 1 indexed citations
7.
Ding, Yinan, Xiaojian Li, Zong Zhuang, et al.. (2024). Neuron-targeted liposomal coenzyme Q10 attenuates neuronal ferroptosis after subarachnoid hemorrhage by activating the ferroptosis suppressor protein 1/coenzyme Q10 system. Acta Biomaterialia. 179. 325–339. 17 indexed citations
8.
9.
Ding, Yinan, Rui Yang, Jiayan Huang, et al.. (2023). Photosensitive small extracellular vesicles regulate the immune microenvironment of triple negative breast cancer. Acta Biomaterialia. 167. 534–550. 13 indexed citations
10.
Li, Han, Yinan Ding, Yanyan Zhao, et al.. (2023). Angiopep-2 Modified Exosomes Load Rifampicin with Potential for Treating Central Nervous System Tuberculosis. International Journal of Nanomedicine. Volume 18. 489–503. 29 indexed citations
11.
He, Chen, Jing Chen, Xiaofei Mo, et al.. (2023). Gold Nanoparticles Enhance the Ability of Radiotherapy to Induce Immunogenic Cell Death in Glioblastoma. International Journal of Nanomedicine. Volume 18. 5701–5712. 15 indexed citations
12.
Ding, Yinan, Ming Xue, Qiusha Tang, et al.. (2022). Immunotherapy-based novel nanoparticles in the treatment of gastrointestinal cancer: Trends and challenges. World Journal of Gastroenterology. 28(37). 5403–5419. 11 indexed citations
13.
Ding, Yinan, Luhong Wang, Han Li, et al.. (2022). Application of lipid nanovesicle drug delivery system in cancer immunotherapy. Journal of Nanobiotechnology. 20(1). 214–214. 46 indexed citations
14.
Wang, Luhong, et al.. (2022). Target and drug predictions for SARS-CoV-2 infection in hepatocellular carcinoma patients. PLoS ONE. 17(5). e0269249–e0269249. 4 indexed citations
15.
He, Chen, Zhiyuan Zhang, Yinan Ding, et al.. (2021). LRP1-mediated pH-sensitive polymersomes facilitate combination therapy of glioblastoma in vitro and in vivo. Journal of Nanobiotechnology. 19(1). 29–29. 56 indexed citations
16.
Ding, Yinan, Rui Yang, Weiping Yu, et al.. (2021). Chitosan oligosaccharide decorated liposomes combined with TH302 for photodynamic therapy in triple negative breast cancer. Journal of Nanobiotechnology. 19(1). 147–147. 59 indexed citations
17.
He, Chen, Jing Chen, Yinan Ding, et al.. (2021). Immunogenic Cell Death Induced by Chemoradiotherapy of Novel pH-Sensitive Cargo-Loaded Polymersomes in Glioblastoma. International Journal of Nanomedicine. Volume 16. 7123–7135. 19 indexed citations
18.
Jia, Gang, Yong Han, Yanli An, et al.. (2018). NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo. Biomaterials. 178. 302–316. 620 indexed citations breakdown →
19.
An, Yanli, Gang Jia, Xihui Wang, et al.. (2018). Facile assembly of upconversion nanoparticle-based micelles for active targeted dual-mode imaging in pancreatic cancer. Journal of Nanobiotechnology. 16(1). 7–7. 63 indexed citations
20.
Ding, Yinan, et al.. (2016). A review on the current development and debate of the global green new deal. 337–340. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026